You just read:

ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance

News provided by

ORIC Pharmaceuticals

Aug 08, 2019, 08:54 ET